Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Tenaya Therapeutics Announces RMAT Designation To TN-401

(RTTNews) - Tenaya Therapeutics, Inc. (TNYA) announced the FDA has granted Regenerative Medicine Advanced Therapy designation to TN-401, Tenaya's gene therapy candidate for the treatment of PKP2-associated arrhythmogenic right ventricular cardiomyopathy. Tenaya's RMAT applicatio

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Read the original at nasdaq.com →

More in Finance & Markets

More from Monday 14 September →